GlassScriptPhysician profile
Christopher J Berry
NPI 1770668527
$2,151.84
in general payments reported to CMS, 2019-2025
13 companies · $47.91 in 2025
The $47.91 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $420 · 2021: $326 · 2022: $45.64 · 2023: $327 · 2024: $540 · 2025: $47.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $534.56 | 2020-2024 | Mitraclip, Cardiomems |
| Medtronic, INC. | $501.38 | 2021-2024 | Venaseal, In.Pact Av, Hawkone |
| Abiomed | $486.12 | 2019-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.76 | 2023-2024 | Jardiance |
| Heartflow, INC. | $141.13 | 2023 | Ffrct |
| Boston Scientific Corporation | $59.45 | 2023-2024 | Varithena Administration Pack, Eluvia |
| Akcea Therapeutics, INC. | $52.33 | 2019 | |
| Cordis US Corp. | $46.58 | 2023-2025 | Mynxgrip |
| Shockwave Medical, INC | $45.64 | 2022 | |
| Medtronic Vascular, INC. | $27.77 | 2020 | |
| Surmodics, INC. | $24.47 | 2024 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce LP Thrombectomy |
| Stryker Corporation | $24.00 | 2025 | Flowtriever |
| Janssen Pharmaceuticals, INC | $15.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.